Diagnosis and Investigation Medications
Definition of Diagnosis and Investigation: Refers to something that is used to determine the cause of an illness or disorder.
Drugs (by generic name) associated with Diagnosis and Investigation
The following drugs and medications are in some way related to, or used in the treatment of Diagnosis and Investigation. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
| Drug Name |
Reviews | Ratings |
||
|---|---|---|---|---|
| sodium iodide-i-131 systemic (More...) | 0 review(s) | Not rated - Be the first | ||
| regadenoson systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| iobenguane I 123 systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| glucagon systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| aminohippurate systemic (More...) | 0 review(s) | Not rated - Be the first | ||
See also...
- Angiocardiography
- Arthrography
- Body Imaging
- Cystourethrography
- Diagnostic Bronchograms
- Digital Subtraction Angiography
- Endoscopy or Radiology Premedication
- Gastrointestinal Tract Examination
- Head Imaging
- Hysterosalpingography
- Intravenous Urography
- Magnetic Resonance Angiography
- Myelography
- Peripheral Angiography
- Radiographic Exam
- Radionuclide Myocardial Perfusion Study
- Renal Arteriography
- Reversal of Dipyridamole During Myocardial Imaging
- Small Intestine Intubation
- Subcutaneous Urography
- Urography
- Vascular Magnetic Resonance Imaging
- Venography
- Visceral Arteriography
Diagnosis and Investigation Medications in the Pipeline
- November 23, 2009 - FDA has posted an Advisory Committee meeting with Photocure to discuss Hexvix NDA
- September 1, 2009 - Photocure ASA (NO) - Hexvix has been granted priority review by the FDA
- July 1, 2009 - Photocure submits application for marketing approval for Hexvix in USA to the FDA
- April 20, 2006 - FDA Requests More Information Related to Hexvix NDA
- February 18, 2009 - Acusphere Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments
- December 11, 2008 - Acusphere Announces Results of FDA Advisory Committee Meeting
- December 8, 2008 - Acusphere, Inc. Announces Posting of Briefing Documents for FDA Cardio Renal Drugs Advisory Committee Meeting on Imagify
- October 13, 2008 - Acusphere's Imagify to be Reviewed at FDA Advisory Committee Meeting on December 10, 2008
- June 30, 2008 - Acusphere Announces FDA Acceptance of Imagify NDA for Detection of Coronary Artery Disease
- April 29, 2008 - Acusphere Submits New Drug Application for FDA Approval of Imagify
- October 21, 2009 - FDA Issues Complete Response Letter for CorVue
- December 19, 2008 - King Pharmaceuticals Announces Submission of New Drug Application for CorVue
